[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pentapeptide-18 Market Insights, Forecast to 2029

November 2023 | 88 pages | ID: G15B799A3A83EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Pentapeptide-18, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Pentapeptide-18, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Pentapeptide-18, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pentapeptide-18 sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Pentapeptide-18 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Pentapeptide-18 sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Hangzhou Rebtech Novel Material Co., Ltd., Spec-Chem, Lipotec S.A.U., Zhejiang Peptites Biotech, KS-V Peptide, GenScript and Sylnta, etc.

By Company
  • Hangzhou Rebtech Novel Material Co., Ltd.
  • Spec-Chem
  • Lipotec S.A.U.
  • Zhejiang Peptites Biotech
  • KS-V Peptide
  • GenScript
  • Sylnta
Segment by Type
  • 98-99%
  • Above 99%
Segment by Application
  • Skin Care Products
  • Cosmetic
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • US & Canada
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • China Taiwan
  • Southeast Asia
    • India
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Turkey
    • Israel
    • GCC Countries
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Pentapeptide-18 production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Pentapeptide-18 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pentapeptide-18 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 9: China by type and by application sales and revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pentapeptide-18 sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.
1 STUDY COVERAGE

1.1 Pentapeptide-18 Product Introduction
1.2 Market by Type
  1.2.1 Global Pentapeptide-18 Market Size by Type, 2018 VS 2022 VS 2029
  1.2.2 98-99%
  1.2.3 Above 99%
1.3 Market by Application
  1.3.1 Global Pentapeptide-18 Market Size by Application, 2018 VS 2022 VS 2029
  1.3.2 Skin Care Products
  1.3.3 Cosmetic
  1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 GLOBAL PENTAPEPTIDE-18 PRODUCTION

2.1 Global Pentapeptide-18 Production Capacity (2018-2029)
2.2 Global Pentapeptide-18 Production by Region: 2018 VS 2022 VS 2029
2.3 Global Pentapeptide-18 Production by Region
  2.3.1 Global Pentapeptide-18 Historic Production by Region (2018-2023)
  2.3.2 Global Pentapeptide-18 Forecasted Production by Region (2024-2029)
  2.3.3 Global Pentapeptide-18 Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan

3 EXECUTIVE SUMMARY

3.1 Global Pentapeptide-18 Revenue Estimates and Forecasts 2018-2029
3.2 Global Pentapeptide-18 Revenue by Region
  3.2.1 Global Pentapeptide-18 Revenue by Region: 2018 VS 2022 VS 2029
  3.2.2 Global Pentapeptide-18 Revenue by Region (2018-2023)
  3.2.3 Global Pentapeptide-18 Revenue by Region (2024-2029)
  3.2.4 Global Pentapeptide-18 Revenue Market Share by Region (2018-2029)
3.3 Global Pentapeptide-18 Sales Estimates and Forecasts 2018-2029
3.4 Global Pentapeptide-18 Sales by Region
  3.4.1 Global Pentapeptide-18 Sales by Region: 2018 VS 2022 VS 2029
  3.4.2 Global Pentapeptide-18 Sales by Region (2018-2023)
  3.4.3 Global Pentapeptide-18 Sales by Region (2024-2029)
  3.4.4 Global Pentapeptide-18 Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America

4 COMPETITION BY MANUFACTURES

4.1 Global Pentapeptide-18 Sales by Manufacturers
  4.1.1 Global Pentapeptide-18 Sales by Manufacturers (2018-2023)
  4.1.2 Global Pentapeptide-18 Sales Market Share by Manufacturers (2018-2023)
  4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pentapeptide-18 in 2022
4.2 Global Pentapeptide-18 Revenue by Manufacturers
  4.2.1 Global Pentapeptide-18 Revenue by Manufacturers (2018-2023)
  4.2.2 Global Pentapeptide-18 Revenue Market Share by Manufacturers (2018-2023)
  4.2.3 Global Top 10 and Top 5 Companies by Pentapeptide-18 Revenue in 2022
4.3 Global Pentapeptide-18 Sales Price by Manufacturers
4.4 Global Key Players of Pentapeptide-18, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
  4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  4.5.2 Global Pentapeptide-18 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Pentapeptide-18, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Pentapeptide-18, Product Offered and Application
4.8 Global Key Manufacturers of Pentapeptide-18, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans

5 MARKET SIZE BY TYPE

5.1 Global Pentapeptide-18 Sales by Type
  5.1.1 Global Pentapeptide-18 Historical Sales by Type (2018-2023)
  5.1.2 Global Pentapeptide-18 Forecasted Sales by Type (2024-2029)
  5.1.3 Global Pentapeptide-18 Sales Market Share by Type (2018-2029)
5.2 Global Pentapeptide-18 Revenue by Type
  5.2.1 Global Pentapeptide-18 Historical Revenue by Type (2018-2023)
  5.2.2 Global Pentapeptide-18 Forecasted Revenue by Type (2024-2029)
  5.2.3 Global Pentapeptide-18 Revenue Market Share by Type (2018-2029)
5.3 Global Pentapeptide-18 Price by Type
  5.3.1 Global Pentapeptide-18 Price by Type (2018-2023)
  5.3.2 Global Pentapeptide-18 Price Forecast by Type (2024-2029)

6 MARKET SIZE BY APPLICATION

6.1 Global Pentapeptide-18 Sales by Application
  6.1.1 Global Pentapeptide-18 Historical Sales by Application (2018-2023)
  6.1.2 Global Pentapeptide-18 Forecasted Sales by Application (2024-2029)
  6.1.3 Global Pentapeptide-18 Sales Market Share by Application (2018-2029)
6.2 Global Pentapeptide-18 Revenue by Application
  6.2.1 Global Pentapeptide-18 Historical Revenue by Application (2018-2023)
  6.2.2 Global Pentapeptide-18 Forecasted Revenue by Application (2024-2029)
  6.2.3 Global Pentapeptide-18 Revenue Market Share by Application (2018-2029)
6.3 Global Pentapeptide-18 Price by Application
  6.3.1 Global Pentapeptide-18 Price by Application (2018-2023)
  6.3.2 Global Pentapeptide-18 Price Forecast by Application (2024-2029)

7 US & CANADA

7.1 US & Canada Pentapeptide-18 Market Size by Type
  7.1.1 US & Canada Pentapeptide-18 Sales by Type (2018-2029)
  7.1.2 US & Canada Pentapeptide-18 Revenue by Type (2018-2029)
7.2 US & Canada Pentapeptide-18 Market Size by Application
  7.2.1 US & Canada Pentapeptide-18 Sales by Application (2018-2029)
  7.2.2 US & Canada Pentapeptide-18 Revenue by Application (2018-2029)
7.3 US & Canada Pentapeptide-18 Sales by Country
  7.3.1 US & Canada Pentapeptide-18 Revenue by Country: 2018 VS 2022 VS 2029
  7.3.2 US & Canada Pentapeptide-18 Sales by Country (2018-2029)
  7.3.3 US & Canada Pentapeptide-18 Revenue by Country (2018-2029)
  7.3.4 United States
  7.3.5 Canada

8 EUROPE

8.1 Europe Pentapeptide-18 Market Size by Type
  8.1.1 Europe Pentapeptide-18 Sales by Type (2018-2029)
  8.1.2 Europe Pentapeptide-18 Revenue by Type (2018-2029)
8.2 Europe Pentapeptide-18 Market Size by Application
  8.2.1 Europe Pentapeptide-18 Sales by Application (2018-2029)
  8.2.2 Europe Pentapeptide-18 Revenue by Application (2018-2029)
8.3 Europe Pentapeptide-18 Sales by Country
  8.3.1 Europe Pentapeptide-18 Revenue by Country: 2018 VS 2022 VS 2029
  8.3.2 Europe Pentapeptide-18 Sales by Country (2018-2029)
  8.3.3 Europe Pentapeptide-18 Revenue by Country (2018-2029)
  8.3.4 Germany
  8.3.5 France
  8.3.6 U.K.
  8.3.7 Italy
  8.3.8 Russia

9 CHINA

9.1 China Pentapeptide-18 Market Size by Type
  9.1.1 China Pentapeptide-18 Sales by Type (2018-2029)
  9.1.2 China Pentapeptide-18 Revenue by Type (2018-2029)
9.2 China Pentapeptide-18 Market Size by Application
  9.2.1 China Pentapeptide-18 Sales by Application (2018-2029)
  9.2.2 China Pentapeptide-18 Revenue by Application (2018-2029)

10 ASIA (EXCLUDING CHINA)

10.1 Asia Pentapeptide-18 Market Size by Type
  10.1.1 Asia Pentapeptide-18 Sales by Type (2018-2029)
  10.1.2 Asia Pentapeptide-18 Revenue by Type (2018-2029)
10.2 Asia Pentapeptide-18 Market Size by Application
  10.2.1 Asia Pentapeptide-18 Sales by Application (2018-2029)
  10.2.2 Asia Pentapeptide-18 Revenue by Application (2018-2029)
10.3 Asia Pentapeptide-18 Sales by Region
  10.3.1 Asia Pentapeptide-18 Revenue by Region: 2018 VS 2022 VS 2029
  10.3.2 Asia Pentapeptide-18 Revenue by Region (2018-2029)
  10.3.3 Asia Pentapeptide-18 Sales by Region (2018-2029)
  10.3.4 Japan
  10.3.5 South Korea
  10.3.6 China Taiwan
  10.3.7 Southeast Asia
  10.3.8 India

11 MIDDLE EAST, AFRICA AND LATIN AMERICA

11.1 Middle East, Africa and Latin America Pentapeptide-18 Market Size by Type
  11.1.1 Middle East, Africa and Latin America Pentapeptide-18 Sales by Type (2018-2029)
  11.1.2 Middle East, Africa and Latin America Pentapeptide-18 Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Pentapeptide-18 Market Size by Application
  11.2.1 Middle East, Africa and Latin America Pentapeptide-18 Sales by Application (2018-2029)
  11.2.2 Middle East, Africa and Latin America Pentapeptide-18 Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Pentapeptide-18 Sales by Country
  11.3.1 Middle East, Africa and Latin America Pentapeptide-18 Revenue by Country: 2018 VS 2022 VS 2029
  11.3.2 Middle East, Africa and Latin America Pentapeptide-18 Revenue by Country (2018-2029)
  11.3.3 Middle East, Africa and Latin America Pentapeptide-18 Sales by Country (2018-2029)
  11.3.4 Brazil
  11.3.5 Mexico
  11.3.6 Turkey
  11.3.7 Israel
  11.3.8 GCC Countries

12 CORPORATE PROFILES

12.1 Hangzhou Rebtech Novel Material Co., Ltd.
  12.1.1 Hangzhou Rebtech Novel Material Co., Ltd. Company Information
  12.1.2 Hangzhou Rebtech Novel Material Co., Ltd. Overview
  12.1.3 Hangzhou Rebtech Novel Material Co., Ltd. Pentapeptide-18 Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.1.4 Hangzhou Rebtech Novel Material Co., Ltd. Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
  12.1.5 Hangzhou Rebtech Novel Material Co., Ltd. Recent Developments
12.2 Spec-Chem
  12.2.1 Spec-Chem Company Information
  12.2.2 Spec-Chem Overview
  12.2.3 Spec-Chem Pentapeptide-18 Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.2.4 Spec-Chem Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
  12.2.5 Spec-Chem Recent Developments
12.3 Lipotec S.A.U.
  12.3.1 Lipotec S.A.U. Company Information
  12.3.2 Lipotec S.A.U. Overview
  12.3.3 Lipotec S.A.U. Pentapeptide-18 Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.3.4 Lipotec S.A.U. Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
  12.3.5 Lipotec S.A.U. Recent Developments
12.4 Zhejiang Peptites Biotech
  12.4.1 Zhejiang Peptites Biotech Company Information
  12.4.2 Zhejiang Peptites Biotech Overview
  12.4.3 Zhejiang Peptites Biotech Pentapeptide-18 Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.4.4 Zhejiang Peptites Biotech Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
  12.4.5 Zhejiang Peptites Biotech Recent Developments
12.5 KS-V Peptide
  12.5.1 KS-V Peptide Company Information
  12.5.2 KS-V Peptide Overview
  12.5.3 KS-V Peptide Pentapeptide-18 Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.5.4 KS-V Peptide Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
  12.5.5 KS-V Peptide Recent Developments
12.6 GenScript
  12.6.1 GenScript Company Information
  12.6.2 GenScript Overview
  12.6.3 GenScript Pentapeptide-18 Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.6.4 GenScript Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
  12.6.5 GenScript Recent Developments
12.7 Sylnta
  12.7.1 Sylnta Company Information
  12.7.2 Sylnta Overview
  12.7.3 Sylnta Pentapeptide-18 Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  12.7.4 Sylnta Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
  12.7.5 Sylnta Recent Developments

13 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

13.1 Pentapeptide-18 Industry Chain Analysis
13.2 Pentapeptide-18 Key Raw Materials
  13.2.1 Key Raw Materials
  13.2.2 Raw Materials Key Suppliers
13.3 Pentapeptide-18 Production Mode & Process
13.4 Pentapeptide-18 Sales and Marketing
  13.4.1 Pentapeptide-18 Sales Channels
  13.4.2 Pentapeptide-18 Distributors
13.5 Pentapeptide-18 Customers

14 PENTAPEPTIDE-18 MARKET DYNAMICS

14.1 Pentapeptide-18 Industry Trends
14.2 Pentapeptide-18 Market Drivers
14.3 Pentapeptide-18 Market Challenges
14.4 Pentapeptide-18 Market Restraints

15 KEY FINDING IN THE GLOBAL PENTAPEPTIDE-18 STUDY


16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Pentapeptide-18 Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 98-99%
Table 3. Major Manufacturers of Above 99%
Table 4. Global Pentapeptide-18 Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Pentapeptide-18 Production by Region: 2018 VS 2022 VS 2029 (Kiloton)
Table 6. Global Pentapeptide-18 Production by Region (2018-2023) & (Kiloton)
Table 7. Global Pentapeptide-18 Production by Region (2024-2029) & (Kiloton)
Table 8. Global Pentapeptide-18 Production Market Share by Region (2018-2023)
Table 9. Global Pentapeptide-18 Production Market Share by Region (2024-2029)
Table 10. Global Pentapeptide-18 Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Pentapeptide-18 Revenue by Region (2018-2023) & (US$ Million)
Table 12. Global Pentapeptide-18 Revenue by Region (2024-2029) & (US$ Million)
Table 13. Global Pentapeptide-18 Revenue Market Share by Region (2018-2023)
Table 14. Global Pentapeptide-18 Revenue Market Share by Region (2024-2029)
Table 15. Global Pentapeptide-18 Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 16. Global Pentapeptide-18 Sales by Region (2018-2023) & (Kiloton)
Table 17. Global Pentapeptide-18 Sales by Region (2024-2029) & (Kiloton)
Table 18. Global Pentapeptide-18 Sales Market Share by Region (2018-2023)
Table 19. Global Pentapeptide-18 Sales Market Share by Region (2024-2029)
Table 20. Global Pentapeptide-18 Sales by Manufacturers (2018-2023) & (Kiloton)
Table 21. Global Pentapeptide-18 Sales Share by Manufacturers (2018-2023)
Table 22. Global Pentapeptide-18 Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 23. Global Pentapeptide-18 Revenue Share by Manufacturers (2018-2023)
Table 24. Pentapeptide-18 Price by Manufacturers 2018-2023 (US$/Ton)
Table 25. Global Key Players of Pentapeptide-18, Industry Ranking, 2021 VS 2022 VS 2023
Table 26. Global Pentapeptide-18 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Pentapeptide-18 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pentapeptide-18 as of 2022)
Table 28. Global Key Manufacturers of Pentapeptide-18, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of Pentapeptide-18, Product Offered and Application
Table 30. Global Key Manufacturers of Pentapeptide-18, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Pentapeptide-18 Sales by Type (2018-2023) & (Kiloton)
Table 33. Global Pentapeptide-18 Sales by Type (2024-2029) & (Kiloton)
Table 34. Global Pentapeptide-18 Sales Share by Type (2018-2023)
Table 35. Global Pentapeptide-18 Sales Share by Type (2024-2029)
Table 36. Global Pentapeptide-18 Revenue by Type (2018-2023) & (US$ Million)
Table 37. Global Pentapeptide-18 Revenue by Type (2024-2029) & (US$ Million)
Table 38. Global Pentapeptide-18 Revenue Share by Type (2018-2023)
Table 39. Global Pentapeptide-18 Revenue Share by Type (2024-2029)
Table 40. Pentapeptide-18 Price by Type (2018-2023) & (US$/Ton)
Table 41. Global Pentapeptide-18 Price Forecast by Type (2024-2029) & (US$/Ton)
Table 42. Global Pentapeptide-18 Sales by Application (2018-2023) & (Kiloton)
Table 43. Global Pentapeptide-18 Sales by Application (2024-2029) & (Kiloton)
Table 44. Global Pentapeptide-18 Sales Share by Application (2018-2023)
Table 45. Global Pentapeptide-18 Sales Share by Application (2024-2029)
Table 46. Global Pentapeptide-18 Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Pentapeptide-18 Revenue by Application (2024-2029) & (US$ Million)
Table 48. Global Pentapeptide-18 Revenue Share by Application (2018-2023)
Table 49. Global Pentapeptide-18 Revenue Share by Application (2024-2029)
Table 50. Pentapeptide-18 Price by Application (2018-2023) & (US$/Ton)
Table 51. Global Pentapeptide-18 Price Forecast by Application (2024-2029) & (US$/Ton)
Table 52. US & Canada Pentapeptide-18 Sales by Type (2018-2023) & (Kiloton)
Table 53. US & Canada Pentapeptide-18 Sales by Type (2024-2029) & (Kiloton)
Table 54. US & Canada Pentapeptide-18 Revenue by Type (2018-2023) & (US$ Million)
Table 55. US & Canada Pentapeptide-18 Revenue by Type (2024-2029) & (US$ Million)
Table 56. US & Canada Pentapeptide-18 Sales by Application (2018-2023) & (Kiloton)
Table 57. US & Canada Pentapeptide-18 Sales by Application (2024-2029) & (Kiloton)
Table 58. US & Canada Pentapeptide-18 Revenue by Application (2018-2023) & (US$ Million)
Table 59. US & Canada Pentapeptide-18 Revenue by Application (2024-2029) & (US$ Million)
Table 60. US & Canada Pentapeptide-18 Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 61. US & Canada Pentapeptide-18 Revenue by Country (2018-2023) & (US$ Million)
Table 62. US & Canada Pentapeptide-18 Revenue by Country (2024-2029) & (US$ Million)
Table 63. US & Canada Pentapeptide-18 Sales by Country (2018-2023) & (Kiloton)
Table 64. US & Canada Pentapeptide-18 Sales by Country (2024-2029) & (Kiloton)
Table 65. Europe Pentapeptide-18 Sales by Type (2018-2023) & (Kiloton)
Table 66. Europe Pentapeptide-18 Sales by Type (2024-2029) & (Kiloton)
Table 67. Europe Pentapeptide-18 Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Pentapeptide-18 Revenue by Type (2024-2029) & (US$ Million)
Table 69. Europe Pentapeptide-18 Sales by Application (2018-2023) & (Kiloton)
Table 70. Europe Pentapeptide-18 Sales by Application (2024-2029) & (Kiloton)
Table 71. Europe Pentapeptide-18 Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Pentapeptide-18 Revenue by Application (2024-2029) & (US$ Million)
Table 73. Europe Pentapeptide-18 Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 74. Europe Pentapeptide-18 Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Pentapeptide-18 Revenue by Country (2024-2029) & (US$ Million)
Table 76. Europe Pentapeptide-18 Sales by Country (2018-2023) & (Kiloton)
Table 77. Europe Pentapeptide-18 Sales by Country (2024-2029) & (Kiloton)
Table 78. China Pentapeptide-18 Sales by Type (2018-2023) & (Kiloton)
Table 79. China Pentapeptide-18 Sales by Type (2024-2029) & (Kiloton)
Table 80. China Pentapeptide-18 Revenue by Type (2018-2023) & (US$ Million)
Table 81. China Pentapeptide-18 Revenue by Type (2024-2029) & (US$ Million)
Table 82. China Pentapeptide-18 Sales by Application (2018-2023) & (Kiloton)
Table 83. China Pentapeptide-18 Sales by Application (2024-2029) & (Kiloton)
Table 84. China Pentapeptide-18 Revenue by Application (2018-2023) & (US$ Million)
Table 85. China Pentapeptide-18 Revenue by Application (2024-2029) & (US$ Million)
Table 86. Asia Pentapeptide-18 Sales by Type (2018-2023) & (Kiloton)
Table 87. Asia Pentapeptide-18 Sales by Type (2024-2029) & (Kiloton)
Table 88. Asia Pentapeptide-18 Revenue by Type (2018-2023) & (US$ Million)
Table 89. Asia Pentapeptide-18 Revenue by Type (2024-2029) & (US$ Million)
Table 90. Asia Pentapeptide-18 Sales by Application (2018-2023) & (Kiloton)
Table 91. Asia Pentapeptide-18 Sales by Application (2024-2029) & (Kiloton)
Table 92. Asia Pentapeptide-18 Revenue by Application (2018-2023) & (US$ Million)
Table 93. Asia Pentapeptide-18 Revenue by Application (2024-2029) & (US$ Million)
Table 94. Asia Pentapeptide-18 Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 95. Asia Pentapeptide-18 Revenue by Region (2018-2023) & (US$ Million)
Table 96. Asia Pentapeptide-18 Revenue by Region (2024-2029) & (US$ Million)
Table 97. Asia Pentapeptide-18 Sales by Region (2018-2023) & (Kiloton)
Table 98. Asia Pentapeptide-18 Sales by Region (2024-2029) & (Kiloton)
Table 99. Middle East, Africa and Latin America Pentapeptide-18 Sales by Type (2018-2023) & (Kiloton)
Table 100. Middle East, Africa and Latin America Pentapeptide-18 Sales by Type (2024-2029) & (Kiloton)
Table 101. Middle East, Africa and Latin America Pentapeptide-18 Revenue by Type (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pentapeptide-18 Revenue by Type (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Pentapeptide-18 Sales by Application (2018-2023) & (Kiloton)
Table 104. Middle East, Africa and Latin America Pentapeptide-18 Sales by Application (2024-2029) & (Kiloton)
Table 105. Middle East, Africa and Latin America Pentapeptide-18 Revenue by Application (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Pentapeptide-18 Revenue by Application (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pentapeptide-18 Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 108. Middle East, Africa and Latin America Pentapeptide-18 Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America Pentapeptide-18 Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East, Africa and Latin America Pentapeptide-18 Sales by Country (2018-2023) & (Kiloton)
Table 111. Middle East, Africa and Latin America Pentapeptide-18 Sales by Country (2024-2029) & (Kiloton)
Table 112. Hangzhou Rebtech Novel Material Co., Ltd. Company Information
Table 113. Hangzhou Rebtech Novel Material Co., Ltd. Description and Major Businesses
Table 114. Hangzhou Rebtech Novel Material Co., Ltd. Pentapeptide-18 Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 115. Hangzhou Rebtech Novel Material Co., Ltd. Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Hangzhou Rebtech Novel Material Co., Ltd. Recent Development
Table 117. Spec-Chem Company Information
Table 118. Spec-Chem Description and Major Businesses
Table 119. Spec-Chem Pentapeptide-18 Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 120. Spec-Chem Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Spec-Chem Recent Development
Table 122. Lipotec S.A.U. Company Information
Table 123. Lipotec S.A.U. Description and Major Businesses
Table 124. Lipotec S.A.U. Pentapeptide-18 Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 125. Lipotec S.A.U. Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Lipotec S.A.U. Recent Development
Table 127. Zhejiang Peptites Biotech Company Information
Table 128. Zhejiang Peptites Biotech Description and Major Businesses
Table 129. Zhejiang Peptites Biotech Pentapeptide-18 Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 130. Zhejiang Peptites Biotech Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Zhejiang Peptites Biotech Recent Development
Table 132. KS-V Peptide Company Information
Table 133. KS-V Peptide Description and Major Businesses
Table 134. KS-V Peptide Pentapeptide-18 Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 135. KS-V Peptide Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. KS-V Peptide Recent Development
Table 137. GenScript Company Information
Table 138. GenScript Description and Major Businesses
Table 139. GenScript Pentapeptide-18 Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 140. GenScript Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. GenScript Recent Development
Table 142. Sylnta Company Information
Table 143. Sylnta Description and Major Businesses
Table 144. Sylnta Pentapeptide-18 Capacity Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 145. Sylnta Pentapeptide-18 Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sylnta Recent Development
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Pentapeptide-18 Distributors List
Table 150. Pentapeptide-18 Customers List
Table 151. Pentapeptide-18 Market Trends
Table 152. Pentapeptide-18 Market Drivers
Table 153. Pentapeptide-18 Market Challenges
Table 154. Pentapeptide-18 Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Pentapeptide-18 Product Picture
Figure 2. Global Pentapeptide-18 Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pentapeptide-18 Market Share by Type in 2022 & 2029
Figure 4. 98-99% Product Picture
Figure 5. Above 99% Product Picture
Figure 6. Global Pentapeptide-18 Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Pentapeptide-18 Market Share by Application in 2022 & 2029
Figure 8. Skin Care Products
Figure 9. Cosmetic
Figure 10. Other
Figure 11. Pentapeptide-18 Report Years Considered
Figure 12. Global Pentapeptide-18 Capacity, Production and Utilization (2018-2029) & (Kiloton)
Figure 13. Global Pentapeptide-18 Production Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Pentapeptide-18 Production Market Share by Region (2018-2029)
Figure 15. Pentapeptide-18 Production Growth Rate in North America (2018-2029) & (Kiloton)
Figure 16. Pentapeptide-18 Production Growth Rate in Europe (2018-2029) & (Kiloton)
Figure 17. Pentapeptide-18 Production Growth Rate in China (2018-2029) & (Kiloton)
Figure 18. Pentapeptide-18 Production Growth Rate in Japan (2018-2029) & (Kiloton)
Figure 19. Global Pentapeptide-18 Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Pentapeptide-18 Revenue 2018-2029 (US$ Million)
Figure 21. Global Pentapeptide-18 Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 22. Global Pentapeptide-18 Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 23. Global Pentapeptide-18 Revenue Market Share by Region (2018-2029)
Figure 24. Global Pentapeptide-18 Sales 2018-2029 ((Kiloton)
Figure 25. Global Pentapeptide-18 Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (Kiloton)
Figure 26. Global Pentapeptide-18 Sales Market Share by Region (2018-2029)
Figure 27. US & Canada Pentapeptide-18 Sales YoY (2018-2029) & (Kiloton)
Figure 28. US & Canada Pentapeptide-18 Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Europe Pentapeptide-18 Sales YoY (2018-2029) & (Kiloton)
Figure 30. Europe Pentapeptide-18 Revenue YoY (2018-2029) & (US$ Million)
Figure 31. China Pentapeptide-18 Sales YoY (2018-2029) & (Kiloton)
Figure 32. China Pentapeptide-18 Revenue YoY (2018-2029) & (US$ Million)
Figure 33. Asia (excluding China) Pentapeptide-18 Sales YoY (2018-2029) & (Kiloton)
Figure 34. Asia (excluding China) Pentapeptide-18 Revenue YoY (2018-2029) & (US$ Million)
Figure 35. Middle East, Africa and Latin America Pentapeptide-18 Sales YoY (2018-2029) & (Kiloton)
Figure 36. Middle East, Africa and Latin America Pentapeptide-18 Revenue YoY (2018-2029) & (US$ Million)
Figure 37. The Pentapeptide-18 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 38. The Top 5 and 10 Largest Manufacturers of Pentapeptide-18 in the World: Market Share by Pentapeptide-18 Revenue in 2022
Figure 39. Global Pentapeptide-18 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 40. Global Pentapeptide-18 Sales Market Share by Type (2018-2029)
Figure 41. Global Pentapeptide-18 Revenue Market Share by Type (2018-2029)
Figure 42. Global Pentapeptide-18 Sales Market Share by Application (2018-2029)
Figure 43. Global Pentapeptide-18 Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Pentapeptide-18 Sales Market Share by Type (2018-2029)
Figure 45. US & Canada Pentapeptide-18 Revenue Market Share by Type (2018-2029)
Figure 46. US & Canada Pentapeptide-18 Sales Market Share by Application (2018-2029)
Figure 47. US & Canada Pentapeptide-18 Revenue Market Share by Application (2018-2029)
Figure 48. US & Canada Pentapeptide-18 Revenue Share by Country (2018-2029)
Figure 49. US & Canada Pentapeptide-18 Sales Share by Country (2018-2029)
Figure 50. U.S. Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 51. Canada Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 52. Europe Pentapeptide-18 Sales Market Share by Type (2018-2029)
Figure 53. Europe Pentapeptide-18 Revenue Market Share by Type (2018-2029)
Figure 54. Europe Pentapeptide-18 Sales Market Share by Application (2018-2029)
Figure 55. Europe Pentapeptide-18 Revenue Market Share by Application (2018-2029)
Figure 56. Europe Pentapeptide-18 Revenue Share by Country (2018-2029)
Figure 57. Europe Pentapeptide-18 Sales Share by Country (2018-2029)
Figure 58. Germany Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 59. France Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 60. U.K. Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 61. Italy Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 62. Russia Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 63. China Pentapeptide-18 Sales Market Share by Type (2018-2029)
Figure 64. China Pentapeptide-18 Revenue Market Share by Type (2018-2029)
Figure 65. China Pentapeptide-18 Sales Market Share by Application (2018-2029)
Figure 66. China Pentapeptide-18 Revenue Market Share by Application (2018-2029)
Figure 67. Asia Pentapeptide-18 Sales Market Share by Type (2018-2029)
Figure 68. Asia Pentapeptide-18 Revenue Market Share by Type (2018-2029)
Figure 69. Asia Pentapeptide-18 Sales Market Share by Application (2018-2029)
Figure 70. Asia Pentapeptide-18 Revenue Market Share by Application (2018-2029)
Figure 71. Asia Pentapeptide-18 Revenue Share by Region (2018-2029)
Figure 72. Asia Pentapeptide-18 Sales Share by Region (2018-2029)
Figure 73. Japan Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 74. South Korea Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 75. China Taiwan Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 76. Southeast Asia Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 77. India Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Pentapeptide-18 Sales Market Share by Type (2018-2029)
Figure 79. Middle East, Africa and Latin America Pentapeptide-18 Revenue Market Share by Type (2018-2029)
Figure 80. Middle East, Africa and Latin America Pentapeptide-18 Sales Market Share by Application (2018-2029)
Figure 81. Middle East, Africa and Latin America Pentapeptide-18 Revenue Market Share by Application (2018-2029)
Figure 82. Middle East, Africa and Latin America Pentapeptide-18 Revenue Share by Country (2018-2029)
Figure 83. Middle East, Africa and Latin America Pentapeptide-18 Sales Share by Country (2018-2029)
Figure 84. Brazil Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 85. Mexico Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 86. Turkey Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 87. Israel Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 88. GCC Countries Pentapeptide-18 Revenue (2018-2029) & (US$ Million)
Figure 89. Pentapeptide-18 Value Chain
Figure 90. Pentapeptide-18 Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed


More Publications